查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1785402

感染監測解決方案市場－全球產業規模、佔有率、趨勢、機會和預測，依產品（軟體、服務）、最終用戶（醫院、長期照護機構）、地區和競爭細分，2020 年至 2030 年預測

Infection Surveillance Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (Software, Service), By End User (Hospitals, Long-term Care Facilities), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球感染監測解決方案市值為 5.5721 億美元，預計在預測期內將實現強勁成長，到 2030 年的複合年成長率為 11.16%。感染監測解決方案是醫療機構（包括醫院）用來向州和聯邦當局報告病患資料的軟體。這些解決方案透過收集院內感染資料、研究感染模式和調節其在社區內的傳播，在醫療保健產業中發揮著至關重要的作用。院內感染是指在醫院或醫療中心內傳播給個人的感染。該軟體會在發生感染時及時向醫院的網際網路通訊協定 (IP) 位址發出警報。這使 HAI 專家和護理師能夠及時為受感染的患者提供適當的治療，以防止疫情爆發。感染監測解決方案是促進醫療機構有效管理院內感染 (HAI) 的重要程序。

市場概覽
預測期 2026-2030
2024年市場規模 5.5721億美元
2030年市場規模 10.4315億美元
2025-2030 年複合年成長率 11.16%
成長最快的領域 醫院
最大的市場 北美洲

例如，2024 年一項分析美國醫院資料的研究顯示，在 COVID-19 大流行期間，與抗生素抗藥性 (AMR) 相關的院內感染增加了 32%，並且在大流行後仍比大流行前水平高出 13%。研究結果強調了疫情對 AMR 的持久影響以及持續感染控制和抗生素管理的必要性。常見的院內感染包括肺炎、胃腸道疾病、泌尿道感染、原發性血液感染和術後感染。院內感染的高發生率是世界各國政府關注的問題，促使各國制定了旨在有效管理和減少這些事件的政策。根據英國衛生安全局 2025 年的報告，7.6% 的患者發現了醫院相關感染，與 2016 年相比上升了 1%。該調查強調了令人擔憂的上升趨勢，並強調需要加強英國醫療機構的感染預防和控制措施。

關鍵市場促進因素

醫院內感染盛行率不斷上升

主要市場挑戰

小型醫療機構部署成本高

主要市場趨勢

基於雲端的軟體解決方案

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球感染監測解決方案市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品（軟體、服務）
    • 依最終使用者（醫院、長期照護機構）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美感染監測解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲感染監測解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太感染監測解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲感染監測解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲感染監測解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球感染監測解決方案市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Cerner Corporation
  • Epic Systems Corporation
  • VigiLanz Corporation
  • Becton, Dickinson and Company
  • Premier Inc.
  • DEB Group Ltd
  • RL Solutions
  • Baxter International Inc. (ICNet International)
  • Gojo Industries Inc.
  • IBM Corporation (Truven Health Analytics)

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 4823

Global Infection Surveillance Solutions Market was valued at USD 557.21 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.16% through 2030F. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 557.21 Million
Market Size 2030USD 1043.15 Million
CAGR 2025-203011.16%
Fastest Growing SegmentHospitals
Largest MarketNorth America

For instance, in 2024, a study analyzing U.S. hospital data revealed that hospital-acquired infections linked to antimicrobial resistance (AMR) rose by 32% during the COVID-19 pandemic and remain 13% higher post-pandemic compared to pre-pandemic levels. The findings underscore the lasting impact of the pandemic on AMR and the need for sustained infection control and antimicrobial stewardship. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents. According to the UK Health Security Agency's 2025 report, healthcare-associated infections were found in 7.6% of patients-marking a 1% rise compared to 2016. The survey highlights a concerning upward trend, emphasizing the need for strengthened infection prevention and control measures across healthcare settings in the UK.

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control. For instance, in 2024, healthcare-associated infections impact approximately 4.3 million patients annually in hospitals across the EU/EEA. These infections pose significant challenges to patient safety, increase hospital stays, and contribute to higher healthcare costs. Reducing their incidence remains a critical priority for healthcare systems, requiring improved infection control practices and enhanced surveillance measures throughout the region.

The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.

Key Market Challenges

High Cost of Deployment for Small Healthcare Organizations

The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.

Key Market Trends

Cloud-based Software Solutions

Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. For instance, according to a 2022 article, 94% of companies worldwide have adopted cloud computing. This widespread adoption reflects the growing reliance on cloud-based technologies to enhance scalability, improve efficiency, and support digital transformation across various industries, making cloud computing a critical component of modern business operations. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.

Key Market Players

  • Cerner Corporation
  • Epic Systems Corporation
  • VigiLanz Corporation
  • Becton, Dickinson and Company
  • Premier Inc.
  • DEB Group Ltd
  • RL Solutions
  • Baxter International Inc. (ICNet International)
  • Gojo Industries Inc.
  • IBM Corporation (Truven Health Analytics)

Report Scope:

In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Surveillance Solutions Market, By Offering:

  • Software
  • Service

Infection Surveillance Solutions Market, By End User:

  • Hospitals
  • Long-term Care Facilities

Infection Surveillance Solutions Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Available Customizations:

Global Infection Surveillance Solutions market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Offering (Software, Service)
    • 5.2.2. By End User (Hospitals, Long-term Care Facilities)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Infection Surveillance Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Offering
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Infection Surveillance Solutions Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Offering
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Infection Surveillance Solutions Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Offering
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Infection Surveillance Solutions Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Offering
        • 6.3.3.2.2. By End User

7. Europe Infection Surveillance Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Offering
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Infection Surveillance Solutions Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Offering
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Infection Surveillance Solutions Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Offering
        • 7.3.2.2.2. By End User
    • 7.3.3. Italy Infection Surveillance Solutions Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Offering
        • 7.3.3.2.2. By End User
    • 7.3.4. France Infection Surveillance Solutions Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Offering
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Infection Surveillance Solutions Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Offering
        • 7.3.5.2.2. By End User

8. Asia-Pacific Infection Surveillance Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Offering
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Infection Surveillance Solutions Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Offering
        • 8.3.1.2.2. By End User
    • 8.3.2. India Infection Surveillance Solutions Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Offering
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Infection Surveillance Solutions Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Offering
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Infection Surveillance Solutions Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Offering
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Infection Surveillance Solutions Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Offering
        • 8.3.5.2.2. By End User

9. South America Infection Surveillance Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Offering
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Infection Surveillance Solutions Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Offering
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Infection Surveillance Solutions Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Offering
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Infection Surveillance Solutions Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Offering
        • 9.3.3.2.2. By End User

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Offering
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Infection Surveillance Solutions Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Offering
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Infection Surveillance Solutions Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Offering
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Infection Surveillance Solutions Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Offering
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Infection Surveillance Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cerner Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Epic Systems Corporation
  • 15.3. VigiLanz Corporation
  • 15.4. Becton, Dickinson and Company
  • 15.5. Premier Inc.
  • 15.6. DEB Group Ltd
  • 15.7. RL Solutions
  • 15.8. Baxter International Inc. (ICNet International)
  • 15.9. Gojo Industries Inc.
  • 15.10. IBM Corporation (Truven Health Analytics)

16. Strategic Recommendations

17. About Us & Disclaimer